Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Sutro Biopharma Inc buy Truist Financial Co.

Start price
€4.14
06.09.23 / 50%
Target price
€23.30
06.09.24
Performance (%)
-8.21%
End price
-
07.09.24
Summary
This prediction is currently being closed. With a performance of -8.21%, the BUY prediction by Truist_Financial_Co_ is trending in the wrong direction. Truist_Financial_Co_ has a follow-up prediction for Sutro Biopharma Inc where he still thinks Sutro Biopharma Inc is a Buy. Truist_Financial_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Sutro Biopharma Inc -6.897% -6.897% -5.970%
iShares Core DAX® -3.429% 5.085% 15.455%
iShares Nasdaq 100 -6.121% 0.593% 16.379%
iShares Nikkei 225® -7.364% 5.479% 6.970%
iShares S&P 500 -4.366% 2.019% 18.650%

Comments by Truist_Financial_Co_ for this prediction

In the thread Sutro Biopharma Inc diskutieren
Prediction Buy
Perf. (%) -8.21%
Target price 23.300
Change
Ends at 06.09.24

Sutro Biopharma, Inc. (NASDAQ: STRO) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $25.00 price target on the stock.
Ratings data for STRO provided by MarketBeat

In the thread Trading Sutro Biopharma Inc
Prediction Buy
Perf. (%) -8.21%
Target price 23.300
Change
Ends at 06.09.24

Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten

Current prediction by Truist_Financial_Co_ for Sutro Biopharma Inc

buy
Sutro Biopharma Inc

Start price
Target price
Perf. (%)
€4.78
03.04.24
€16.65
03.04.25
-22.18%
05.09.24

Stopped prediction by Truist_Financial_Co_ for Sutro Biopharma Inc

buy
Sutro Biopharma Inc

Start price
Target price
Perf. (%)
€3.88
16.08.24
€13.63
16.08.25
-4.12%
05.09.24